Lalit Bajaj
Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis | 8 | 2022 | 87 | 3.460 |
Why?
| | Emergency Service, Hospital | 60 | 2026 | 2301 | 3.240 |
Why?
| | Sepsis | 11 | 2025 | 640 | 2.180 |
Why?
| | Lactic Acid | 3 | 2017 | 302 | 1.330 |
Why?
| | Bacterial Infections | 2 | 2022 | 246 | 1.210 |
Why?
| | Appendicitis | 11 | 2022 | 148 | 1.160 |
Why?
| | Hospitals, Pediatric | 13 | 2025 | 555 | 1.140 |
Why?
| | Child | 78 | 2026 | 22537 | 1.110 |
Why?
| | Oxygen Inhalation Therapy | 4 | 2022 | 182 | 1.110 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 1131 | 1.060 |
Why?
| | Epilepsy | 2 | 2020 | 375 | 0.890 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 248 | 0.850 |
Why?
| | Fractures, Bone | 5 | 2021 | 414 | 0.840 |
Why?
| | Endocrine System Diseases | 3 | 2015 | 35 | 0.810 |
Why?
| | Emergencies | 4 | 2015 | 175 | 0.810 |
Why?
| | Pediatric Emergency Medicine | 2 | 2024 | 23 | 0.780 |
Why?
| | Infant | 34 | 2026 | 10022 | 0.780 |
Why?
| | Medical Overuse | 3 | 2024 | 30 | 0.710 |
Why?
| | Soft Tissue Infections | 1 | 2022 | 39 | 0.710 |
Why?
| | Emergency Medical Services | 6 | 2019 | 696 | 0.710 |
Why?
| | Chorioamnionitis | 1 | 2022 | 45 | 0.700 |
Why?
| | Mastitis | 1 | 2021 | 6 | 0.700 |
Why?
| | Craniocerebral Trauma | 3 | 2019 | 176 | 0.700 |
Why?
| | Acute Pain | 2 | 2021 | 54 | 0.690 |
Why?
| | Quality Improvement | 9 | 2026 | 1285 | 0.690 |
Why?
| | Gastroenteritis | 1 | 2022 | 63 | 0.680 |
Why?
| | Ketamine | 5 | 2017 | 132 | 0.680 |
Why?
| | Decision Support Systems, Clinical | 6 | 2025 | 265 | 0.680 |
Why?
| | Staphylococcal Infections | 2 | 2022 | 388 | 0.650 |
Why?
| | Home Care Services | 2 | 2022 | 280 | 0.650 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 113 | 0.650 |
Why?
| | Skin Diseases | 1 | 2022 | 149 | 0.640 |
Why?
| | Shock, Septic | 4 | 2025 | 215 | 0.620 |
Why?
| | Underage Drinking | 4 | 2021 | 22 | 0.610 |
Why?
| | Child, Preschool | 39 | 2026 | 11774 | 0.600 |
Why?
| | Humans | 95 | 2026 | 144261 | 0.580 |
Why?
| | Adolescent | 49 | 2026 | 22281 | 0.580 |
Why?
| | Metabolic Diseases | 2 | 2015 | 113 | 0.580 |
Why?
| | Retrospective Studies | 30 | 2025 | 17009 | 0.570 |
Why?
| | Plant Extracts | 1 | 2020 | 187 | 0.570 |
Why?
| | Cannabidiol | 1 | 2020 | 136 | 0.550 |
Why?
| | Anticonvulsants | 1 | 2020 | 234 | 0.540 |
Why?
| | Practice Patterns, Physicians' | 7 | 2022 | 1347 | 0.530 |
Why?
| | Hospitalization | 8 | 2022 | 2424 | 0.510 |
Why?
| | Medical Marijuana | 1 | 2019 | 123 | 0.510 |
Why?
| | Patient Admission | 2 | 2019 | 218 | 0.510 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 124 | 0.490 |
Why?
| | Anti-Bacterial Agents | 6 | 2025 | 1906 | 0.480 |
Why?
| | Dronabinol | 1 | 2019 | 247 | 0.480 |
Why?
| | Hospital Mortality | 3 | 2022 | 1027 | 0.470 |
Why?
| | Capnography | 1 | 2015 | 16 | 0.460 |
Why?
| | Oximetry | 1 | 2016 | 126 | 0.450 |
Why?
| | Infant, Newborn | 13 | 2022 | 6424 | 0.450 |
Why?
| | Pediatrics | 7 | 2019 | 1112 | 0.440 |
Why?
| | Health Care Costs | 1 | 2018 | 421 | 0.440 |
Why?
| | Male | 59 | 2026 | 72035 | 0.440 |
Why?
| | Airway Management | 1 | 2015 | 79 | 0.430 |
Why?
| | Fever | 2 | 2022 | 311 | 0.430 |
Why?
| | Female | 58 | 2026 | 77976 | 0.420 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 96 | 0.420 |
Why?
| | Asthma | 3 | 2022 | 1767 | 0.420 |
Why?
| | Patient Readmission | 3 | 2018 | 756 | 0.410 |
Why?
| | Clinical Laboratory Techniques | 2 | 2018 | 96 | 0.410 |
Why?
| | Electronic Health Records | 8 | 2025 | 1169 | 0.400 |
Why?
| | Prospective Studies | 21 | 2025 | 7970 | 0.390 |
Why?
| | Anesthetics, Dissociative | 3 | 2017 | 46 | 0.390 |
Why?
| | Patient Discharge | 4 | 2020 | 977 | 0.370 |
Why?
| | Triage | 1 | 2015 | 249 | 0.360 |
Why?
| | Patient Transfer | 1 | 2015 | 206 | 0.350 |
Why?
| | Intensive Care Units | 2 | 2015 | 916 | 0.350 |
Why?
| | Delivery of Health Care | 1 | 2018 | 940 | 0.350 |
Why?
| | Emergency Treatment | 4 | 2020 | 124 | 0.350 |
Why?
| | Ambulatory Care | 3 | 2021 | 597 | 0.340 |
Why?
| | Disease Management | 1 | 2015 | 643 | 0.340 |
Why?
| | Abdominal Pain | 6 | 2016 | 146 | 0.320 |
Why?
| | Caregivers | 3 | 2017 | 1047 | 0.320 |
Why?
| | Guideline Adherence | 4 | 2020 | 586 | 0.310 |
Why?
| | Sensitivity and Specificity | 9 | 2019 | 1983 | 0.310 |
Why?
| | United States | 16 | 2026 | 15876 | 0.300 |
Why?
| | Drug Prescriptions | 3 | 2022 | 280 | 0.300 |
Why?
| | Practice Guidelines as Topic | 5 | 2018 | 1559 | 0.300 |
Why?
| | Diagnostic Errors | 3 | 2022 | 175 | 0.300 |
Why?
| | Risk Assessment | 6 | 2019 | 3637 | 0.290 |
Why?
| | Machine Learning | 3 | 2025 | 585 | 0.290 |
Why?
| | Vomiting | 3 | 2008 | 130 | 0.280 |
Why?
| | Cohort Studies | 10 | 2020 | 5935 | 0.280 |
Why?
| | Ondansetron | 1 | 2008 | 19 | 0.280 |
Why?
| | Cannabis | 3 | 2021 | 509 | 0.270 |
Why?
| | Quality of Health Care | 3 | 2023 | 688 | 0.270 |
Why?
| | Head Injuries, Closed | 2 | 2018 | 49 | 0.270 |
Why?
| | Antiemetics | 1 | 2008 | 49 | 0.260 |
Why?
| | Cross-Sectional Studies | 13 | 2026 | 5813 | 0.260 |
Why?
| | Canada | 4 | 2024 | 428 | 0.250 |
Why?
| | Appendectomy | 5 | 2022 | 89 | 0.240 |
Why?
| | Pain Management | 2 | 2020 | 405 | 0.240 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2006 | 9 | 0.240 |
Why?
| | Time Factors | 11 | 2020 | 7155 | 0.240 |
Why?
| | Registries | 6 | 2025 | 2382 | 0.230 |
Why?
| | Magnesium | 2 | 2020 | 155 | 0.230 |
Why?
| | Medical Audit | 1 | 2025 | 77 | 0.230 |
Why?
| | Law Enforcement | 1 | 2025 | 48 | 0.230 |
Why?
| | Police | 1 | 2025 | 45 | 0.220 |
Why?
| | Hypnotics and Sedatives | 2 | 2006 | 214 | 0.220 |
Why?
| | Benchmarking | 1 | 2026 | 188 | 0.220 |
Why?
| | Spain | 2 | 2021 | 48 | 0.210 |
Why?
| | Length of Stay | 4 | 2025 | 1335 | 0.200 |
Why?
| | Intussusception | 1 | 2003 | 25 | 0.200 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 242 | 0.200 |
Why?
| | Enema | 1 | 2003 | 46 | 0.200 |
Why?
| | Unnecessary Procedures | 1 | 2024 | 53 | 0.200 |
Why?
| | Anaphylaxis | 1 | 2005 | 102 | 0.200 |
Why?
| | Alcoholism | 2 | 2021 | 808 | 0.190 |
Why?
| | Acute Disease | 7 | 2020 | 1028 | 0.190 |
Why?
| | Metabolism, Inborn Errors | 1 | 2003 | 42 | 0.190 |
Why?
| | Intubation, Intratracheal | 2 | 2015 | 320 | 0.190 |
Why?
| | Critical Care | 2 | 2021 | 694 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 6 | 2018 | 2730 | 0.180 |
Why?
| | Physical Examination | 2 | 2015 | 236 | 0.180 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2022 | 17 | 0.180 |
Why?
| | Drug Utilization | 3 | 2020 | 166 | 0.180 |
Why?
| | Brain Injuries, Traumatic | 2 | 2018 | 441 | 0.180 |
Why?
| | Communication Barriers | 2 | 2014 | 124 | 0.180 |
Why?
| | Prevalence | 2 | 2021 | 2815 | 0.170 |
Why?
| | Parental Consent | 1 | 2021 | 25 | 0.170 |
Why?
| | Musculoskeletal Pain | 1 | 2021 | 43 | 0.170 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1054 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5389 | 0.160 |
Why?
| | Community-Acquired Infections | 1 | 2023 | 174 | 0.160 |
Why?
| | Antimicrobial Stewardship | 1 | 2023 | 129 | 0.160 |
Why?
| | Mass Screening | 2 | 2019 | 1332 | 0.160 |
Why?
| | Organ Dysfunction Scores | 2 | 2022 | 52 | 0.160 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 338 | 0.160 |
Why?
| | Treatment Outcome | 8 | 2020 | 11643 | 0.160 |
Why?
| | Waiting Lists | 1 | 2022 | 263 | 0.150 |
Why?
| | Drug Hypersensitivity | 1 | 2021 | 90 | 0.150 |
Why?
| | Heuristics | 1 | 2019 | 12 | 0.150 |
Why?
| | Tracheostomy | 2 | 2015 | 142 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 114 | 0.150 |
Why?
| | Half-Life | 1 | 2019 | 151 | 0.150 |
Why?
| | Biological Availability | 1 | 2019 | 142 | 0.150 |
Why?
| | Advisory Committees | 1 | 2020 | 227 | 0.140 |
Why?
| | First Aid | 1 | 2018 | 14 | 0.140 |
Why?
| | Tissue Distribution | 1 | 2019 | 327 | 0.140 |
Why?
| | Time-to-Treatment | 2 | 2025 | 240 | 0.140 |
Why?
| | Marijuana Abuse | 1 | 2021 | 211 | 0.140 |
Why?
| | Severity of Illness Index | 4 | 2015 | 2917 | 0.140 |
Why?
| | Hospitals | 2 | 2021 | 727 | 0.140 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 102 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2021 | 279 | 0.140 |
Why?
| | Global Health | 2 | 2015 | 394 | 0.130 |
Why?
| | Community Health Centers | 1 | 2018 | 59 | 0.130 |
Why?
| | Incidence | 5 | 2019 | 2870 | 0.130 |
Why?
| | Motivation | 1 | 2022 | 605 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 542 | 0.130 |
Why?
| | Healthcare Disparities | 3 | 2020 | 725 | 0.130 |
Why?
| | Bronchodilator Agents | 1 | 2018 | 182 | 0.130 |
Why?
| | Veins | 1 | 2017 | 68 | 0.130 |
Why?
| | Oxygen | 1 | 2022 | 995 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 171 | 0.130 |
Why?
| | Intestinal Perforation | 1 | 2017 | 44 | 0.130 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 454 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 187 | 0.120 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 6021 | 0.120 |
Why?
| | Inappropriate Prescribing | 1 | 2017 | 63 | 0.120 |
Why?
| | Administration, Oral | 1 | 2019 | 847 | 0.120 |
Why?
| | Propofol | 1 | 2017 | 85 | 0.120 |
Why?
| | Prognosis | 4 | 2022 | 4278 | 0.120 |
Why?
| | Algorithms | 2 | 2019 | 1834 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1646 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2020 | 309 | 0.120 |
Why?
| | Anesthetics, Intravenous | 2 | 2015 | 69 | 0.120 |
Why?
| | Ultrasonography | 2 | 2018 | 768 | 0.120 |
Why?
| | Ultrasonography, Doppler | 2 | 2014 | 126 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2019 | 301 | 0.120 |
Why?
| | Laryngeal Masks | 1 | 2015 | 18 | 0.110 |
Why?
| | Arteries | 1 | 2017 | 258 | 0.110 |
Why?
| | Decision Support Techniques | 3 | 2017 | 454 | 0.110 |
Why?
| | Colorado | 7 | 2020 | 4562 | 0.110 |
Why?
| | Logistic Models | 5 | 2025 | 2104 | 0.110 |
Why?
| | Marijuana Smoking | 1 | 2019 | 250 | 0.110 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 264 | 0.110 |
Why?
| | Data Collection | 1 | 2018 | 633 | 0.110 |
Why?
| | Larynx | 1 | 2015 | 56 | 0.110 |
Why?
| | Informed Consent | 1 | 2017 | 198 | 0.110 |
Why?
| | Spinal Fractures | 1 | 2015 | 73 | 0.110 |
Why?
| | Virus Diseases | 1 | 2017 | 216 | 0.110 |
Why?
| | Confidence Intervals | 2 | 2013 | 333 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 126 | 0.110 |
Why?
| | Morbidity | 1 | 2015 | 323 | 0.110 |
Why?
| | Analgesia | 2 | 2005 | 105 | 0.100 |
Why?
| | Body Temperature | 1 | 2015 | 228 | 0.100 |
Why?
| | International Classification of Diseases | 1 | 2015 | 143 | 0.100 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 201 | 0.100 |
Why?
| | Trachea | 1 | 2015 | 261 | 0.100 |
Why?
| | Blood Cell Count | 2 | 2013 | 54 | 0.100 |
Why?
| | Burns | 1 | 2018 | 376 | 0.100 |
Why?
| | Patient Compliance | 1 | 2017 | 585 | 0.090 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 49 | 0.090 |
Why?
| | Telephone | 2 | 2012 | 174 | 0.090 |
Why?
| | Etomidate | 1 | 2012 | 18 | 0.090 |
Why?
| | Patient Selection | 1 | 2017 | 719 | 0.090 |
Why?
| | Asymptomatic Diseases | 1 | 2013 | 97 | 0.090 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 93 | 0.090 |
Why?
| | Patient Care Team | 1 | 2018 | 686 | 0.090 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 316 | 0.090 |
Why?
| | Age Factors | 2 | 2016 | 3313 | 0.090 |
Why?
| | Translating | 1 | 2012 | 50 | 0.090 |
Why?
| | Poisoning | 1 | 2013 | 119 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 812 | 0.090 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.090 |
Why?
| | ROC Curve | 3 | 2022 | 612 | 0.090 |
Why?
| | Emergency Medicine | 2 | 2024 | 261 | 0.090 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2111 | 0.080 |
Why?
| | Post-Concussion Syndrome | 1 | 2014 | 184 | 0.080 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 427 | 0.080 |
Why?
| | Heart Rate | 1 | 2015 | 849 | 0.080 |
Why?
| | Brain Concussion | 2 | 2016 | 638 | 0.080 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 189 | 0.080 |
Why?
| | Risk | 2 | 2012 | 909 | 0.080 |
Why?
| | Language | 2 | 2012 | 321 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1409 | 0.080 |
Why?
| | Intraocular Pressure | 1 | 2012 | 327 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 291 | 0.080 |
Why?
| | Reproducibility of Results | 5 | 2019 | 3403 | 0.080 |
Why?
| | Electrocardiography | 1 | 2013 | 660 | 0.080 |
Why?
| | Spinal Puncture | 1 | 2009 | 17 | 0.080 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 423 | 0.080 |
Why?
| | Continuity of Patient Care | 1 | 2012 | 287 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2012 | 1487 | 0.070 |
Why?
| | Bacteriological Techniques | 1 | 2009 | 68 | 0.070 |
Why?
| | Pregnancy | 1 | 2022 | 7180 | 0.070 |
Why?
| | Communication | 2 | 2019 | 961 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2012 | 545 | 0.070 |
Why?
| | Glasgow Coma Scale | 2 | 2017 | 213 | 0.070 |
Why?
| | Age Distribution | 1 | 2009 | 397 | 0.070 |
Why?
| | Drug Overdose | 1 | 2013 | 367 | 0.070 |
Why?
| | Critical Illness | 1 | 2015 | 889 | 0.070 |
Why?
| | Anti-Asthmatic Agents | 1 | 2010 | 251 | 0.070 |
Why?
| | Adult | 8 | 2022 | 40262 | 0.070 |
Why?
| | Urinalysis | 2 | 2013 | 80 | 0.070 |
Why?
| | Biomarkers | 2 | 2016 | 4254 | 0.070 |
Why?
| | Venous Thromboembolism | 1 | 2011 | 324 | 0.060 |
Why?
| | United Kingdom | 2 | 2018 | 336 | 0.060 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 527 | 0.060 |
Why?
| | Mental Disorders | 1 | 2016 | 1138 | 0.060 |
Why?
| | Community Medicine | 1 | 2006 | 6 | 0.060 |
Why?
| | Anesthesia Recovery Period | 1 | 2006 | 29 | 0.060 |
Why?
| | Fentanyl | 3 | 2015 | 126 | 0.060 |
Why?
| | Injections, Intramuscular | 1 | 2006 | 141 | 0.060 |
Why?
| | Recurrence | 2 | 2012 | 1134 | 0.060 |
Why?
| | Adrenergic Agonists | 1 | 2005 | 4 | 0.060 |
Why?
| | Potassium | 1 | 2005 | 152 | 0.060 |
Why?
| | Histamine H1 Antagonists | 1 | 2005 | 24 | 0.060 |
Why?
| | Feedback | 1 | 2025 | 181 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2025 | 247 | 0.050 |
Why?
| | Attitude | 1 | 2006 | 259 | 0.050 |
Why?
| | Hemolysis | 1 | 2005 | 243 | 0.050 |
Why?
| | Stroke | 1 | 2012 | 1254 | 0.050 |
Why?
| | Fluid Therapy | 1 | 2005 | 147 | 0.050 |
Why?
| | Documentation | 1 | 2025 | 197 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 383 | 0.050 |
Why?
| | Radiography | 2 | 2015 | 842 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2008 | 2025 | 0.050 |
Why?
| | Fasting | 1 | 2004 | 276 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2002 | 38 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2025 | 1087 | 0.040 |
Why?
| | Midazolam | 2 | 2015 | 72 | 0.040 |
Why?
| | Penicillins | 1 | 2021 | 61 | 0.040 |
Why?
| | Neutrophils | 2 | 2016 | 1134 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2005 | 533 | 0.040 |
Why?
| | Prescriptions | 1 | 2020 | 76 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 94 | 0.040 |
Why?
| | National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2019 | 1 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2022 | 3592 | 0.040 |
Why?
| | Survival Rate | 1 | 2005 | 2088 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2017 | 1044 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 170 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 106 | 0.040 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2018 | 19 | 0.040 |
Why?
| | Wales | 1 | 2018 | 26 | 0.040 |
Why?
| | Reference Values | 2 | 2014 | 797 | 0.040 |
Why?
| | Information Dissemination | 1 | 2020 | 220 | 0.030 |
Why?
| | Abdomen, Acute | 1 | 2018 | 21 | 0.030 |
Why?
| | Portugal | 1 | 2017 | 10 | 0.030 |
Why?
| | Ireland | 1 | 2017 | 32 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2020 | 280 | 0.030 |
Why?
| | Quality Control | 1 | 2018 | 163 | 0.030 |
Why?
| | Research | 1 | 2021 | 428 | 0.030 |
Why?
| | Outpatients | 1 | 2021 | 439 | 0.030 |
Why?
| | New Zealand | 1 | 2017 | 54 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 401 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 218 | 0.030 |
Why?
| | Australia | 1 | 2017 | 286 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2016 | 164 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Risk Factors | 3 | 2019 | 10699 | 0.030 |
Why?
| | Program Evaluation | 1 | 2020 | 946 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2016 | 316 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 329 | 0.030 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 32 | 0.030 |
Why?
| | Androstanols | 1 | 2015 | 30 | 0.030 |
Why?
| | Medical Order Entry Systems | 1 | 2015 | 40 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2015 | 117 | 0.030 |
Why?
| | Pilot Projects | 1 | 2019 | 1867 | 0.020 |
Why?
| | Clinical Enzyme Tests | 1 | 2013 | 9 | 0.020 |
Why?
| | Salicylates | 1 | 2013 | 29 | 0.020 |
Why?
| | Students | 1 | 2019 | 661 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1533 | 0.020 |
Why?
| | Respiratory Tract Infections | 1 | 2017 | 396 | 0.020 |
Why?
| | Time Management | 1 | 2012 | 21 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2013 | 108 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2014 | 600 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2013 | 519 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1682 | 0.020 |
Why?
| | Recovery of Function | 1 | 2016 | 706 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1129 | 0.020 |
Why?
| | Acetaminophen | 1 | 2013 | 264 | 0.020 |
Why?
| | North America | 1 | 2010 | 310 | 0.020 |
Why?
| | Parents | 1 | 2018 | 1401 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2010 | 538 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2926 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 704 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 13990 | 0.020 |
Why?
| | Seizures, Febrile | 1 | 2006 | 22 | 0.020 |
Why?
| | Potassium Acetate | 1 | 2005 | 2 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 41 | 0.010 |
Why?
| | Respiration Disorders | 1 | 2004 | 77 | 0.010 |
Why?
| | Respiratory Tract Diseases | 1 | 2005 | 175 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 35762 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 850 | 0.010 |
Why?
| | Analgesics | 1 | 2005 | 228 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 2134 | 0.010 |
Why?
|
|
Bajaj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|